Watch J. Wykrzykowska N. Van Mieghem and G. Tarantini discussing on how TAVI is moving into younger, lower- and intermediate-risk populations in a roundtable format . Patient selection, valve choice and key implantation techniques are discussed together with insights from the VANTAGE study, confirming the Navitor™ TAVI System’s safety and effectiveness in low- and intermediate-risk patients.